Filamon
Filamon secures exclusive licence for groundbreaking anti-cancer drug
Feb 2, 2023
Filamon was awarded an exclusive license for a groundbreaking experimental anti-cancer drug developed by Australian university scientists. Australian clinical-stage drug development company, Filamon Limited, announced that it has been awarded an exclusive licence to a ...
chat_bubble0 Comment
visibility342 Views
New Australian biotechnology company to develop a drug blocking prostate cancer
Dec 6, 2022
A new Australian bio-technology company secures a licence to develop a drug to block the development of metastatic prostate cancer. Filamon Limited, an Australian drug development company focused on blocking the forces that turn cancer ...
chat_bubble0 Comment
visibility438 Views
Healthcare Channel acknowledges the traditional custodians of the lands where we live, learn and work. We pay our respects to Elders past, present and emerging.
All rights reserved. © Healthcare channel powered by Akolade.